BENZOAKANIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITION Russian patent published in 1998 - IPC

Abstract RU 2110512 C1

FIELD: pharmaceutical industry. SUBSTANCE: present invention describes compounds of formula (I): wherein R1 is phenyl optionally substituted by halogen atom, CF3 or naphthyl; R2 is H, C1-C4-alkoxy group, halogen or S(O)n(C1-C4-alkyl; X is CH2, CHCH3, -CH(OH)-, -CO- or - O-, n is 2, and pharmaceutically acceptable salts. The present invention also describes pharmaceutical compositions which comprise compounds of formula (I) as active ingredient. EFFECT: improved properties of pharmaceutical compositions. 9 cl, 2 tbl

Similar patents RU2110512C1

Title Year Author Number
BENZOPYRANES, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT 1994
  • Aleksandr Roderik Makkenzi
  • Sandra Marina Monagan
RU2122000C1
3-AZETHIDINYLALKYLPIPERIDINES OR PYRROLIDINES AS TACHYKININE ANTAGONISTS, METHODS OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT 1996
  • Aleksandr Roderik Makkenzi
  • Allan Patrik Marchington
  • Donal'D Stjuart Middleton
  • Sandra Dora Medous
RU2158264C2
DERIVATIVES OF OXA- OR THIADIZOLE, METHODS OF THEIR SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITION 1997
  • Aleksandr Roderik Makkenzi
  • Ehntoni Vud
  • Robert Dzhon Bass
RU2162848C2
DERIVATIVES OF (AZETHIDINE-1-YLALKYL)-LACTAMES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT OF HUMANS WHEN PATIENTS ARE TREATED BY PRODUCING ANTAGONISTIC EFFECT ON TACHYKININ ACTING IN HUMAN NK-, NK- AND NK-RECEPTORS OR IN THEIR COMBINATION 1995
  • Makenzi Aleksandr Roderik
  • Marchington Alan Patrik
  • Middlton Donal'D Stjuart
  • Midouz Sandra Dora
RU2150468C1
METHOD OF PREPARING (S)-ENANTIOMERS 1994
  • Stefen Chellendzher
RU2114103C1
QUINOXALINE DERIVATIVES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION 1995
  • Majkl Dzhonatan Frej
  • Charl'Z Ehrik Moubrej
  • Alan Stoubi
RU2135484C1
DERIVATIVES OF TRIAZOLE, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND PROPHYLAXIS OF FUNGAL INFECTIONS, INTERMEDIATE COMPOUND 1997
  • Mertiashou Charlz V.
  • Grin Stjuart
  • Stefenson Piter T.
RU2176244C2
METHOD OF SYNTHESIS OF TRIAZOLES, ULTIMATE AND INTERMEDIATE COMPOUNDS OF METHOD 1996
  • Majkl Batters
  • Dzhuli Ehnn Kharrison
  • Alan Dzhon Pettman
RU2156760C2
(R)-(METHYLAMINOSULFONYLMETHYL)-3-(N-METHYLPYRROLIDINE-2-YL- -METHYL)-1H-INDOLE FUMARATE, METHOD OF ITS PREPARING, AGENT FOR TREATMENT OF MIRGAINE, PHARMACEUTICAL COMPOSITION FOR MIGRAINE TREATMENT 1996
  • Martin Dzhejms Uites
RU2161618C2
CRYSTALLINE POLYMORPHOUS FORM OF (S,S,S)-(N-(1-[2-CARBOXY-3- -N-MESYLLYSYLAMINO)PROPYL]-1-CYCLOPENTYLCARBONYL)TYROSINE, METHODS OF ITS SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF PATIENT TREATMENT 1994
  • Piter Dzhejms Dann
  • Majkl Lesli Kh'Juz
RU2131869C1

RU 2 110 512 C1

Authors

Rodzher Piter Dikinson[Gb]

Kevin Nejl Dehk[Gb]

Dzhon Stil[Gb]

Dates

1998-05-10Published

1993-09-14Filed